110 computer-science-intern "https:" "https:" "https:" "U.S" positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
27 Jan 2026 Job Information Organisation/Company UNIVERSITY OF SOUTHAMPTON Research Field Psychological sciences Researcher Profile Recognised Researcher (R2) First Stage Researcher (R1) Application
-
The Department of Politics and International Relations (PAIR) at the University of Southampton, UK, is seeking a highly motivated Postdoctoral Researcher (100% FTE) to join the Horizon Europe
-
We are delighted to welcome applications for a Research Fellow post within the ESRC Connecting Generations programme to examine intergenerational flows of support in later life and the increased
-
of the work, candidates must be exempt or eligible for an ATAS certificate; more details on ATAS can be found here: https://www.gov.uk/guidance/academic-technology-approval-scheme . Informal enquiries: Prof
-
including maternity, paternity or adoption leave, disability or illness. Both the University of Southampton and Chemistry are proud to hold Athena Swan Silver Awards. Where to apply Website https
-
for the digital services that underpin the work of NIHRCC and also offer support to the School. Further information can be found at: https://www.nihr.ac.uk . You are encouraged to review our operational priorities
-
Application Deadline 20 Jan 2026 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
a Horizon Europe Pathfinder science-to-technology breakthrough, targeting a paradigm shift in fabricating a novel optically active crystal – rare-earth (RE) doped sapphire (REDS). The EIC-funded
-
The WorldPop research group, within the School of Geography and Environmental Sciences at the University of Southampton is an award winning, multi-sectoral team of researchers, technicians and
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic